Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiarrhythmic Trial With Dronedarone in Moderate to Severe CHF Evaluating Morbidity Decrease

NCT00696631 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00696631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00696631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiarrhythmic Trial With Dronedarone in Moderate to Severe CHF Evaluating Morbidity Decrease
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2002
Completion date
August 31, 2003
Enrollment
653 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure